Factors associated with quality of care in inflammatory bowel diseases: a view from patient's side using the IQCARO quality of care decalogue.
Crohn’s disease
Inflammatory bowel diseases
Patients
Quality of health care
Surveys and questionnaires
Ulcerative colitis
Journal
BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547
Informations de publication
Date de publication:
29 Oct 2021
29 Oct 2021
Historique:
received:
28
12
2020
accepted:
13
10
2021
entrez:
30
10
2021
pubmed:
31
10
2021
medline:
3
11
2021
Statut:
epublish
Résumé
Quality of care (QoC) is a highly important topic in inflammatory bowel disease (IBD). We recently elaborated a decalogue of QoC indicators (IQCARO-QoC) developed by IBD patients. The aim of the present study was to assess the factors associated with patients' evaluation of QoC in Spain using the IQCARO-QoC Decalogue recently developed by IBD patients. A survey including patients' socio-demographic and clinical characteristics, and the IQCARO-QoC Decalogue, was completed by IBD patients. We described patients' assessment of QoC across Spanish patients. A univariable and multivariable analysis was performed to explore the associations between patients' characteristics and QoC. Questionnaires from 788 participant patients were analysed. Participants' mean age was 43.4 years, 63% were females and 58% had Crohn's disease. The mean QoC score was 8.1 (± 2.4 SD) points out of a maximum of 10. Items with the lowest score were related to the provision of information and the implication of the medical team throughout the entire patient care. Factors associated with better QoC scores included: being employed better disease control, fewer numbers of unscheduled visits, and being followed by a gastroenterologist specialized in IBD. Spanish patients' reported QoC seems to be globally good although there is room for improvement, especially in providing adequate information to patients. Care provided by specialized IBD gastroenterologists seems to be related with higher QoC scores.
Sections du résumé
BACKGROUND
BACKGROUND
Quality of care (QoC) is a highly important topic in inflammatory bowel disease (IBD). We recently elaborated a decalogue of QoC indicators (IQCARO-QoC) developed by IBD patients. The aim of the present study was to assess the factors associated with patients' evaluation of QoC in Spain using the IQCARO-QoC Decalogue recently developed by IBD patients.
METHODS
METHODS
A survey including patients' socio-demographic and clinical characteristics, and the IQCARO-QoC Decalogue, was completed by IBD patients. We described patients' assessment of QoC across Spanish patients. A univariable and multivariable analysis was performed to explore the associations between patients' characteristics and QoC.
RESULTS
RESULTS
Questionnaires from 788 participant patients were analysed. Participants' mean age was 43.4 years, 63% were females and 58% had Crohn's disease. The mean QoC score was 8.1 (± 2.4 SD) points out of a maximum of 10. Items with the lowest score were related to the provision of information and the implication of the medical team throughout the entire patient care. Factors associated with better QoC scores included: being employed better disease control, fewer numbers of unscheduled visits, and being followed by a gastroenterologist specialized in IBD.
CONCLUSIONS
CONCLUSIONS
Spanish patients' reported QoC seems to be globally good although there is room for improvement, especially in providing adequate information to patients. Care provided by specialized IBD gastroenterologists seems to be related with higher QoC scores.
Identifiants
pubmed: 34715812
doi: 10.1186/s12876-021-01968-2
pii: 10.1186/s12876-021-01968-2
pmc: PMC8555225
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
412Subventions
Organisme : Merck Sharp and Dohme (SP)
ID : funded the study and medical writing assistance
Informations de copyright
© 2021. The Author(s).
Références
J Crohns Colitis. 2019 Jan 1;13(1):127-137
pubmed: 30423033
Bull World Health Organ. 2017 May 1;95(5):368-374
pubmed: 28479638
Dig Liver Dis. 2017 Sep;49(9):997-1002
pubmed: 28595949
J Crohns Colitis. 2008 Jun;2(2):181-8
pubmed: 21172209
Inflamm Bowel Dis. 2010 Jun;16(6):982-92
pubmed: 19918968
Patient. 2021 Sep;14(5):625-634
pubmed: 33709214
Can J Gastroenterol Hepatol. 2014 Nov;28(10):536-42
pubmed: 25390615
Am J Gastroenterol. 2001 Dec;96(12):3329-36
pubmed: 11774945
J Crohns Colitis. 2013 Oct;7(9):e367-74
pubmed: 23528836
Inflamm Bowel Dis. 2020 Apr 11;26(5):782-791
pubmed: 31634907
Inflamm Bowel Dis. 2019 Feb 21;25(3):479-489
pubmed: 30169698
Patient Educ Couns. 2016 Apr;99(4):631-637
pubmed: 26590706
J Crohns Colitis. 2014 Dec;8(12):1642-52
pubmed: 25113898
Scand J Gastroenterol. 2016;51(4):434-41
pubmed: 26635189
J Womens Health Gend Based Med. 2000 Jul-Aug;9(6):657-65
pubmed: 10957754
J Gend Specif Med. 2003;6(4):30-5
pubmed: 14714448
Epidemiology. 2007 Nov;18(6):800-4
pubmed: 18049194